Topic Archives: CRISPR

Please indulge Doc Gumshoe while he presents his musings on what’s going on in general in the health-care arena, and in particular, which new drugs are getting the FDA blessing and why, as well as which ones are getting the short straw.   My impressions and conclusions are in some cases only loosely based on […]

Here’s a bit from the email that Matt McCall sent out introducing his lastest teaser ad: “When it comes down to it, there are really just three ways to get truly rich in the stock market. You can put thousands into the market every year, hold for decades, and retire with a fortune. You can […]

The article below was originally published on November 27, 2017, when Jeff Brown’s ads promoting the “God Key” started to show up in our inboxes. It has not been updated or revised, but the new versions of the ad from Brown are very similar to the ones we covered in November, including the description of […]

Fear Of Missing Out is such a big deal that it gets its own acronym in my book (FOMO — and a clever FOMO-fueling website here), and it drives investors to take huge chances just so they don’t have to worry about missing a chance at stupendous gains. That’s what many newsletter ads use to […]

Comments

  • Here is a question for Doc Gumshoe: Recently there was a gigantic scientific breakthrough, comparable if not greater th...

  • Worrying development for CRISPR stocks. A recent study has flagged a new safety signal that could potentially hurt the d...

  • I would 100% Stay away from Celgene. Insider here. Their management is pretty awful and abusive to really smart people. ...

  • I've just googled "better than crispr" and got various results. One of them is a Motley Fool piece about Precision BioSc...

  • Sir, The article gives very useful information about CRISPR technology for gene editing. I have couple of questions. Wha...

  • I have a question about COVID-19 and immunity and something Doc Gumshoe wrote goes with it. He wrote in the article abov...

  • Interesting and informative article on CRISPR development!...

  • Bacterial CRISPR DNA Sequences that bind to bacteriophage genetic sequences may be a hurdle in treating individual path...

  • Not to take anything from their years of research but CRISPR Therapeutics already has several people cured from T1D. Wha...

  • My apologies Travis, at the time I wrote this I hadn't read your entire article yet (now I have). Thanks for a GREAT art...

  • appian, crispr, and crowdstrike are def in there...

  • Editing the genome of a living human being is a big deal. CRISPR therapies are amazing, but they will almost certainly ...

  • In 2013 Charpentier co-founded CRISPR Therapeutics...

  • All of the CRISPR stocks are speculative, and they are riding a speculative fervor right now -- partly because they've m...

  • I'm still fixated on EDIT, maybe too much so. They went down to about $70 on 12/30 (were into the $90's I believe shortl...

  • I know he's pushed CRSPR which is very much up. I understand there are also four other companies associated with CRISP...

  • CRISPR Cure - '"Emmanuelle Charpentier and Jennifer Doudna are awarded the Nobel Prize in Chemistry 2020 for discover...

  • CRISPR itself is doing pretty well. It's up to about $140/share. Brown pitched Crisper while it was in the $60 range...

  • A COUPLE OF MONTHS BACK I HEARD A AUDIO FROM JEFF BROWNS TALKING ABOUT A CRISPR COMPANY BLIND CURE-- AT THE END OF AUDIO...

  • just got Dylan Jovine's Behind the Markets pitch in my email. sounds too good. anyone have any input on his CRISPR biote...

  • What is the crispr biotech stock that will cure blindness that Jeff Brown is pushing in his exponential tech investor ne...

  • AS of Aug 15, the newsletter pitch is the same, something happening soon, Dylan says: https://go.behindthemarkets.com/li...

  • Biotech companies Beam and Editas are set to merge. And they will release “exciting” details about their progress wi...

  • can someone refer the company who developed hearing loss therapy with CRISPR ? the small cap Jeff mentioned...

  • I believe it is EDIT (Editas Medicine), it’s a CRISPR stock. I hope someone else can confirm as I could not make it ...

  • Great advice, Travis. I've got a basket of biotechs and every single one dropped 10-20% immediately after I purchased th...

  • Latest News by Jeff Brown, “FDA Fast Tracks $6.8 Billion Miracle Antibiotic for July Approval One microcap owns the ...

  • Does it help to have a look at the insider trading? Here's for CRISPR: https://www.sec.gov/cgi-bin/own-disp?action=get...

  • EDITAS has a lot of promise - a lot! But it's only a cure for one very rare form of blindness, as I think I pointed ou...

  • whats the CRISPR small cap cure for blindness? Its supposed to go 1000% as soon as tomorrow morning. Any more thought Do...

  • Then Read up on Editas Medicines (EDIT), who is treating LCA-10 Genetic Blindness, and has dosed it's first human. The ...

  • When I first heard this pitch, I dug around and figured out what it was. I bought into Editas I think a couple weeks ag...

  • Hi Stuart: I am still waiting for the EDIT's results for the first trial results to come out and give a good jump to th...

  • Hi Kazito, You sound a bit like me, an older newbie. I actually hedged my bets and put $1,500 into EDIT and the same in...

  • So Travis, what do you think of Dylan Jovine saying he has the biggest and best of all...Bigger than AI, 5G, Crispr, etc...

  • The promises of imminent riches are always misleading, and almost always either exaggerated or just made up to spur you ...

  • I assume you mean Jeff Brown, no? Not Jeff Bezos (of Amazon)? Brown has indeed been touting Editas for a long time...

  • I like Editas but it a long run play. Quite a bit has been made on Crispr Technology already, so I may be pleasantly su...

  • He has several newsletters and has to churn out at least a few new stocks a month to his subscribers — can’t just li...

  • Which one did he mention to sell? I have a few Crispr companies but don’t have that report. I have the near future rep...

  • I really think Jeff is on to something with CRISPR technology. He just signaled a sell signal on one and a buy signal ...

  • Edit not crispr...

  • Prollem is, CRISPR tech also delivers a free bonus--deletions and substitutions that were not intended. Oops....

  • He does say it was founded by the folks who discovered CRISPR...

  • John Boston’s,,, It’s CRISPR technology, that’s supposed to cure inherited blindness....

  • Hello Doc G, Your article was generally well done and informative. Thanks! However, being both a molecular biolo...

  • I'll be the first to admit I've taken some long shots over the years, the most recent being CRNT. Hopefully, CRNT will b...

  • I can see CRISPR easily sliding from your quoted price. What is today's price? I'll look it up one of these weeks....

  • " I were dabbling in CRISPR I’d probably just buy a basket of the stocks (EDIT, NTLA, CRSP) and try to ignore them for...

  • Or own ARKG (I own a bit): 1 CRISPR THERAPEUTICS AG CRSP 10.57 2 ILLUMINA INC ILMN 9.94 3 INVITAE CORP NVTA 8.22 4 INTEL...

  • CRISPR has huge potential but hyping a phase 1 clinical trial before a minimum of 10 patients are enrolled and treated i...

  • CRISPR rechnology and research bears watching. I met with the doctors who discovered the gene for Alzheimer's and they ...

  • Thank you for your thoughtful detailing on the processes currently underway and in realignment in the scale of time invo...

  • Unravelling mystery of how, when DNA replicates https://www.sciencedaily.com/releases/2018/12/181227150644.htm Have an a...

  • Thanks MJ, This is the real reason I read stockgumshoe.Having worked in the “Health care” profession for decad...

  • Cancer treatment and info on this company stock symbol. What is crispr company stock symbol? Thank you! Greatly appreci...

  • Drug companies cant touch this tech, without paying DEARLY for licensing. CRISPR tech is getting to the root of the pro...

  • There've been a lot of uncertainties around the CRISPR companies, but I think right now the elephant in the room is the ...

  • Many highly interesting comments for which many thanks. I will attempt to respond (& perhaps actually answer) to as ma...

  • You failed to mention advancements covering the efficacy of CRISPR technology...

  • It's got to be one of the three small biotechs that have access to CRISPR - Crispr Therapeutics (CRSP), Intellia Therape...

  • Good plan, Dave. I'm 58, do not have time to GAMBLE with hard-earned cash. DRIP plans invested in solid companies tha...

  • A good perspective. And when it comes to Sangamo, it seems to me that Zinc Finger "editing" is 10-20 years ahead of CRI...

  • CRISPR might eventually be able to edit the human genome safely, but we are years away from that, assuming scientificall...

  • So the Big Parma influenced FDA is going to cut the throat of the medical mafia, which is almost 20% of our GDP, by sanc...

  • It’s Editas, MIT and Harvard have been in a patent battle with Berkeley and Berkeley lost. It’s my understanding th...

  • Crispr, CRSP, EDIT, NTLA are all promising companies, as is Beam Therapeutics (private company)....

  • I have recently become aware of two books, 'The Telomerase Revolution' by Dr. Michael Fossel and 'A Crack In Creation' b...

  • Well, this one would have been a pretty good buy... having doubled since the promotional piece was written. The other cr...

  • $YTEN, $CLXT fp & #CRISPR stocks... Eatin' CRISPR food in 5 years maybe https://www.ozy.com/fast-forward/you-could-b...

  • Those are certainly the primary CRISPR names that get teased all the time, though I haven't looked at that actual ad yet...

  • $JNJ, $GILD, #EDIT etc. - As gene editing explodes, a new report from Goldman says Chinese groups are seizing the lead o...

  • Regarding CRISPR technology, Has anyone investigated the NEXGEN teaser about a $200 biotech stock that could reach 1 mil...

  • Market analysts believe that the patent dispute will conclude in the most common way observed in the past cases – both...

  • I wouldn't put too much credence in the Fool's CRISPR doomsayer act. The paper cited by the Fool suggests ways around th...

  • Hi John, Here's a couple of articles on the concern: Arbor Biotechnologies Discovers New CRISPR System Utilizing its ...

  • backoffice, According to The Motley Fool, almost all CRISPR stocks are headed to 0. Not sure that I agree with their...

  • There are a lot of rare/orphan diseases that no big pharma companies will touch that could be impacted by CRISPR technol...

  • Ha!! Caught again - thank you for being the best detective on Market Street....

  • CRISPR is a research tool/technique, not a drug. The first uses of CRISPR in humans are just beginning with initial cli...

  • Readers may be interested in looking at the January 2018 JP Morgan Healthcare presentation by SGMO. Their gene editing ...

  • I like instead the company Sangamo (SGMO). Their gene editing technology (zinc finger) appears more robust and safer th...

  • The technology, research and development behind the three forerunners on the CRISPR gene editing front is so hyped that ...

  • Incidentally, this patent fight between the major CRISPR "discovery" researchers and their respective institutions does ...

  • Yes, its Editas (EDIT). But the patent dispute was resolved a year ago. Not new news. They do have a good proprietary...

  • When I checked the worth of each company mentioned above I found that a smaller company may also be involved in the actu...

  • Please see following article: "Court Rules Against Berkeley CRISPR Patent (//www.investopedia.com/news/court-rules-again...

  • $CAPR, the rest of the market and institutions have no faith in CAPR. What could go wrong here. Besides it's one of the ...

  • I looked into SGNO and their method of zinc fingers seems to have had successful tests so far and they eluded that CRISP...

  • $CLLS - Two Issued U.S. Patents Granted to Cellectis for CRISPR Use in T-Cells http://www.cellectis.com/en/press/two-i...

  • $NoTicker...maybe $CRISPR? Cooking this week has been rough. Several bad slices and almost lost a finger tip. I hope ...

  • $GeneEditing $CRISPR Beautiful. Thank you!...

  • $GeneEditing $CRISPR “CRISPR gene-editing systems 3D animation (video)” #Fantastic Video - watch what it actu...

  • The Chart of the Day belongs to CRISPR Therapeutics (CRSP). I found the Biomedical stock by using Barchart to sort toda...

  • $DFFN in & swingin' - 8K & exhibits filed with the SEC http://www.snl.com/Cache/c391818209.html view all docz http://in...

  • Goldman: Setting the stage for oncology M&A in 2018 Tax reform unlocks ~$160bn ex-US cash for potential M&A Potential ...

  • #CRISPR - Crispr Therapeutics AG (NASDAQ: $CRSP) was the recipient of unusually large options trading on Thursday. In...

  • CrIspr Disappointing. Dreams dashed of becoming hollywood tv gameshow host if I'm immune, and they can't switch off a...

  • #ARTH out but decided to begin getting back in with some lifting of the haze; #conference call: Just a quick monster t...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info